NCT03068897View on ClinicalTrials.gov

Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 3, 2017

Primary Completion Date

July 11, 2018

Study Completion Date

October 11, 2018

Conditions
Low Back Pain
Interventions
DRUG

Metaxalone

Metaxalone 400-800mg

DRUG

Tizanidine

Tizanidine 2-4mg

DRUG

Baclofen

Baclofen 10-20mg

DRUG

Ibuprofen 600 mg

Ibuprofen

BEHAVIORAL

Educational intervention

Research personnel will provide each patient with a 15-minute educational intervention. This will be based on NIAMS's Handout on Health: Back Pain information webpage (available at http://www.niams.nih.gov/Health\_Info/Back\_Pain/default.asp) Research personnel will review each section of the information sheet with the patient and elicit questions.

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT03068897 - Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain | Biotech Hunter | Biotech Hunter